Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
ABCG1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
TFF3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TFF2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TFF1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TMPRSS3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
UMODL1-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
UMODL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
UBASH3A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RSPH1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF295-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZBTB21 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC37A1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C2CD2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PRDM15 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on